For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220401:nRSA9861Ga&default-theme=true
RNS Number : 9861G Spire Healthcare Group PLC 01 April 2022
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BNLPYF73
Issuer Name
SPIRE HEALTHCARE GROUP PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Bank of America Corporation
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Name City of registered office Country of registered office
MERRILL LYNCH INTERNATIONAL London United Kingdom
5. Date on which the threshold was crossed or reached
30-Mar-2022
6. Date on which Issuer notified
01-Apr-2022
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 3.001101 3.423794 6.424895 25771406
Position of previous notification (if applicable) 2.867633 3.429889 6.297522
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00BNLPYF73 12037953 3.001101
Sub Total 8.A 12037953 3.001101%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is % of voting rights
exercised/converted
Right to Recall 111936 0.027906
Sub Total 8.B1 111936 0.027906%
8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Swaps 11/04/2022 N/A Cash 3366000 0.839155
Swaps 24/05/2022 N/A Cash 2169589 0.540886
Swaps 27/06/2022 N/A Cash 1847239 0.460523
Swaps 06/07/2022 N/A Cash 1355000 0.337806
Swaps 19/07/2022 N/A Cash 753000 0.187725
Swaps 29/07/2022 N/A Cash 43428 0.010827
Swaps 21/09/2022 N/A Cash 1205 0.000300
Swaps 16/11/2022 N/A Cash 208069 0.051872
Swaps 04/01/2023 N/A Cash 2770859 0.690784
Swaps 31/01/2023 N/A Cash 14483 0.003611
Swaps 01/02/2023 N/A Cash 74 0.000018
Swaps 07/02/2023 N/A Cash 1092000 0.272239
Swaps 27/12/2023 N/A Cash 571 0.000142
Sub Total 8.B2 13621517 3.395888%
9. Information in relation to the person subject to the notification
obligation
2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
Bank of America Corporation Merrill Lynch International 3.001101 5.987220%
Bank of America Corporation BofA Securities Europe SA
Bank of America Corporation Bank of America, National Association
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
01-Apr-2022
13. Place Of Completion
United Kingdom
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END HOLUAOARURUSRAR